Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiome and intestinal mucosal ecosystem represent a complex, symbiotic network consisting of trillions of microorganisms and the host's intestinal lining. This ecosystem serves as a critical biological interface that regulates nutrient metabolism, synthesizes essential vitamins, and orchestrates the development and function of the host immune system (Thursby & Juge, 2017). The mucosal barrier, composed of epithelial cells and a protective mucus layer, prevents the systemic translocation of luminal contents while facilitating cross-talk between microbes and immune cells (Vancamelbeke & Vermeire, 2017). Dysbiosis, or the imbalance of this ecosystem, is strongly associated with various pathologies, including inflammatory bowel disease, metabolic syndrome, and susceptibility to enteric infections like Clostridioides difficile (Lynch & Pedersen, 2016). Therapeutic interventions such as probiotics, prebiotics, and fecal microbiota transplantation (FMT) aim to restore ecological balance and barrier function (Fan & Pedersen, 2021). While not a single molecular target, this system is increasingly recognized as a "virtual organ" that can be modulated to achieve systemic therapeutic effects.
Modulation of microbial composition, restoration of commensal diversity, enhancement of mucosal barrier integrity, and production of metabolic byproducts like short-chain fatty acids (SCFAs).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiome and intestinal mucosal ecosystem.